Correspondence 0000950170-25-037893 from Adicet Bio, Inc. (ACET) (CIK 0001720580) (ACET)
Adicet Bio, Inc. (ACET) (CIK 0001720580)
Date: March 12, 2025 · CIK: 0001720580 · Accession: 0000950170-25-037893
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285609
Letter
Re: Adicet Bio, Inc.: Registration Statement on Form S-3, filed March 6, 2025 (File No. 333-285609), as amended Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “ Act ”), Adicet Bio, Inc. (the “ Company ”) hereby requests that the effective date of the above-referenced registration statement, as amended (the “ Registration Statement ”) be accelerated to March 14, 2025, at 4:01 p.m. Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with Goodwin Procter LLP by calling Gabriela Morales-Rivera at (617) 570-1329. If you have any questions regarding this request, please contact Gabriela Morales-Rivera.
Adicet Bio, Inc. 131 Dartmouth Street, Floor 3 Boston, Massachusetts 02116
March 12, 2025
Via EDGAR Transmission
United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549
Sincerely,
Adicet Bio, Inc.
/s/ Chen Schor
Chen Schor President and Chief Executive Officer
Show Raw Text
CORRESP 1 filename1.htm CORRESP Adicet Bio, Inc. 131 Dartmouth Street, Floor 3 Boston, Massachusetts 02116 March 12, 2025 Via EDGAR Transmission United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Re: Adicet Bio, Inc.: Registration Statement on Form S-3, filed March 6, 2025 (File No. 333-285609), as amended Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “ Act ”), Adicet Bio, Inc. (the “ Company ”) hereby requests that the effective date of the above-referenced registration statement, as amended (the “ Registration Statement ”) be accelerated to March 14, 2025, at 4:01 p.m. Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with Goodwin Procter LLP by calling Gabriela Morales-Rivera at (617) 570-1329. If you have any questions regarding this request, please contact Gabriela Morales-Rivera. Sincerely, Adicet Bio, Inc. /s/ Chen Schor Chen Schor President and Chief Executive Officer cc: Nick Harvey, Chief Financial Officer, Adicet Bio, Inc. Danielle Lauzon, Esq., Goodwin Procter LLP Gabriela Morales-Rivera, Esq., Goodwin Procter LLP